JPRN-jRCT2031210173已完成未知
Adynovate Special Drug Use Result Survey (Perioperative administration)
Contact for Clinical Trial Information0 个研究点目标入组 17 人开始时间: 2021年6月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants with blood coagulation factor VIII (FVIII) deficiency who received this drug during surgery or treatment after the start date of this survey.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Special Drug Use-results survey for long term administration of Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral SolutioMild to moderately severe dementia of the Alzheimer's typeJPRN-UMIN000017151Janssen Pharmaceutical K.K.600
已完成
不适用
Special Drug Use-results survey for long-term administration of Stelarapsoriasis vulgaris, psoriatic arthritisJPRN-UMIN000015899Janssen Pharmaceutical K.K.1,500
招募中
不适用
Special Drug Use Results Survey for the use of Symtuza in pregnant womeJPRN-UMIN000037488Janssen Pharmaceutical K.K.3
招募中
Unknown
Special Drug Use-Results Survey (All-Case Surveillance) to Investigate Safety and Effectiveness in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Empaveli in the Post-Marketing Clinical Use in JapaParoxysmal nocturnal hemoglobinuriaJPRN-jRCT2031230275Shimmoto Naoki100
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Tramcet Combination TabletsChronic painJPRN-UMIN000015901Janssen Pharmaceutical K.K.1,200